|
⚲
|
| Keyboard |
| Lacasse Louis P
✚
|
|
|---|---|
| CIK # | 0001216489 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001216489] | |
| 4 | [0001216489] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Histogen Inc | |
| Lacasse Louis P |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Histogen Inc CNAT
Stock Option (Right to Buy) · derivative
|
2015-06-11 | Grant | 15,000 | $0.00 | |
|
Histogen Inc CNAT
Stock Option (Right to Buy) · derivative
|
2014-06-19 | Grant | 15,000 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Other | 12,537 | $11.00 | 137,907 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Conversion | 673,400 | ||
|
Histogen Inc CNAT
Stock Option (Right to Buy) · derivative
|
2013-07-30 | Grant | 30,000 | $0.00 | |
|
Histogen Inc CNAT
Series B Preferred Stock · derivative
|
2013-07-30 | Conversion | 5,555,556 | ||
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Buy | 123,950 | $11.00 | 1,363,450 |